fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
New article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”
ChemRar Announced Successful Completion of Phase II Clinical Trials of AB5080
Read All Our News >

Pharma News

Sanofi ends research in diabetes, narrows units to spur profit
FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations
Amneal to buy generic pharmaceuticals provider AvKAR for $340m
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: